Wimbledon Neurocare Limited - Accounts to registrar (filleted) - small 18.2

Wimbledon Neurocare Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v19.2.0.596 07487836 Board of Directors Board of Directors 1.1.18 31.12.18 31.12.18 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure074878362017-12-31074878362018-12-31074878362018-01-012018-12-31074878362016-12-31074878362017-01-012017-12-31074878362017-12-3107487836ns15:EnglandWales2018-01-012018-12-3107487836ns14:PoundSterling2018-01-012018-12-3107487836ns10:Director12018-01-012018-12-3107487836ns10:Director22018-01-012018-12-3107487836ns10:PrivateLimitedCompanyLtd2018-01-012018-12-3107487836ns10:SmallEntities2018-01-012018-12-3107487836ns10:AuditExempt-NoAccountantsReport2018-01-012018-12-3107487836ns10:SmallCompaniesRegimeForDirectorsReport2018-01-012018-12-3107487836ns10:SmallCompaniesRegimeForAccounts2018-01-012018-12-3107487836ns10:FullAccounts2018-01-012018-12-3107487836ns10:CompanySecretary12018-01-012018-12-3107487836ns10:RegisteredOffice2018-01-012018-12-3107487836ns5:CurrentFinancialInstruments2018-12-3107487836ns5:CurrentFinancialInstruments2017-12-3107487836ns5:ShareCapital2018-12-3107487836ns5:ShareCapital2017-12-3107487836ns5:SharePremium2018-12-3107487836ns5:SharePremium2017-12-3107487836ns5:RetainedEarningsAccumulatedLosses2018-12-3107487836ns5:RetainedEarningsAccumulatedLosses2017-12-3107487836ns5:PlantMachinery2018-01-012018-12-3107487836ns5:PlantMachinery2017-12-3107487836ns5:PlantMachinery2018-12-3107487836ns5:PlantMachinery2017-12-3107487836ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-12-3107487836ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-12-3107487836ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2018-12-3107487836ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2017-12-31


REGISTERED NUMBER: 07487836 (England and Wales)













WIMBLEDON NEUROCARE LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST DECEMBER 2018






WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2018










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


WIMBLEDON NEUROCARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST DECEMBER 2018







DIRECTORS: Dr A Y M J Al-Memar
Dr O J F Foster





SECRETARY: S Kumar





REGISTERED OFFICE: Unit 1 College Fields
16 Prince George Road
London
SW19 2PT





REGISTERED NUMBER: 07487836 (England and Wales)





ACCOUNTANTS: Sinclairs Bartrum Lerner
Chartered Accountants
39A Welbeck Street
London
W1G 8DH

WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

BALANCE SHEET
31ST DECEMBER 2018

2018 2017
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 167,704 145,790

CURRENT ASSETS
Debtors 5 257,022 197,869
Cash at bank 645,343 806,516
902,365 1,004,385
CREDITORS
Amounts falling due within one year 6 148,490 157,637
NET CURRENT ASSETS 753,875 846,748
TOTAL ASSETS LESS CURRENT
LIABILITIES

921,579

992,538

CAPITAL AND RESERVES
Called up share capital 514,048 514,048
Share premium 240,240 240,240
Retained earnings 167,291 238,250
SHAREHOLDERS' FUNDS 921,579 992,538

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2018 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

BALANCE SHEET - continued
31ST DECEMBER 2018


The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 25th September 2019 and were signed on its
behalf by:




Dr A Y M J Al-Memar - Director



Dr O J F Foster - Director


WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2018


1. STATUTORY INFORMATION

Wimbledon Neurocare Limited is a private company, limited by shares , registered in England and Wales. The
company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The significant accounting policies applied in the preparation of these financial statements are set out below.
These policies have been consistently applied to all years presented unless otherwise stated.

The financial statements are prepared in Pound Sterling which is the functional currency of the company and
rounded to nearest pound.

Turnover
Turnover comprises revenue recognised by the company in respect of a range of services for the management of
neurological conditions, hearing related conditions and balance disorders which includes assessment, diagnosis
and treatment during the year, exclusive of Value Added Tax and trade discounts.

Services provided to patients are recognised as turnover according to the date when the treatments are provided.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 20% straight line on cost and 15% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to
the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that
have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the
timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they
will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to profit or loss in the period to which they relate.

WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST DECEMBER 2018


2. ACCOUNTING POLICIES - continued

Debtors and creditors
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at
transaction price. Any losses arising from impairment are recognised in the profit and loss account in other
administrative expenses.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2017 - 5 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1st January 2018 705,166
Additions 81,354
At 31st December 2018 786,520
DEPRECIATION
At 1st January 2018 559,376
Charge for year 59,440
At 31st December 2018 618,816
NET BOOK VALUE
At 31st December 2018 167,704
At 31st December 2017 145,790

5. DEBTORS
2018 2017
£    £   
Amounts falling due within one year:
Trade debtors 177,345 149,598
Other debtors 73,477 41,271
250,822 190,869

Amounts falling due after more than one year:
Other debtors 6,200 7,000

Aggregate amounts 257,022 197,869

WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST DECEMBER 2018


6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Trade creditors 96,514 95,235
Taxation and social security 36,187 51,543
Other creditors 15,789 10,859
148,490 157,637

7. OTHER FINANCIAL COMMITMENTS

Total Operating lease commitment as at the balance sheet date £59,902.